Compared with the luminal A and B subtypes, the HER2+ BC and TNBC subtypes show abundant T-cell infiltration, and activation of T-cell-mediated immune responses enhances immune-related antitumor activity in these subtypes [36]. This evidence concerns the gene ERBB2 and breast cancer.